Results 301 to 310 of about 1,262,720 (386)
Global Strategy on Human Resources for Health: Workforce 2030—A Five-Year Check-In
Michelle McIsaac+4 more
doaj +1 more source
Nerve Excitability in Asymptomatic Carriers and Amyotrophic Lateral Sclerosis Patients With C9orf72
ABSTRACT Objective We investigated the effects of C9orf72 mutation carriership on peripheral nerve excitability in asymptomatic individuals from families with a history of C9orf72 amyotrophic lateral sclerosis (ALS) and patients. Methods We included 47 asymptomatic individuals from families with a history of C9orf72 ALS, of whom 23 were carriers (C9 ...
Diederik J. L. Stikvoort García+3 more
wiley +1 more source
The National Dementia Workforce Study: Methods for Surveying Community Clinicians Who Provide Care to People With Dementia. [PDF]
White EM+14 more
europepmc +1 more source
ABSTRACT Background Plasma p‐tau181 has proven to be a promising diagnostic and prognostic tool in the earliest phases of Alzheimer's disease (AD). We aimed to evaluate the prognostic role of p‐tau181 in predicting conversion to AD dementia and worsening in cognition in mild cognitive impairment (MCI) and subjective cognitive decline (SCD).
Giulia Giacomucci+12 more
wiley +1 more source
A review of recruitment and retention strategies in U.S. local health departments: insights and practical solutions. [PDF]
Houck O+5 more
europepmc +1 more source
Moyamoya Disease and the Risk of Parkinson's Disease
ABSTRACT Objectives Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by the progressive narrowing of arteries at the base of the brain, forming abnormal collateral vascular networks. While vascular parkinsonism is noted in MMD, its link to Parkinson's disease (PD) has not been explored.
Dallah Yoo+9 more
wiley +1 more source
Issue Overview: Public Health Workforce Development in Hawai'i: Building a Post Pandemic Future to Achieve Health Equity. [PDF]
Sentell T+3 more
europepmc +1 more source
Objective Gastrointestinal perforation (GIP) is a rare and life‐threatening safety concern associated with JAK inhibitors (JAKi). We aimed to review the evidence regarding the risk of GIP associated with the use of JAKi in patients with rheumatoid arthritis (RA) using a systematic review and network meta‐analysis approach.
Thipsukhon Sathapanasiri+7 more
wiley +1 more source
Editorial: Building tomorrow's biomedical workforce: advancing scholarship, innovation and systemic change. [PDF]
Bankston A, Layton RL, Van Wart A.
europepmc +1 more source